Harika Derya Tamer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Harika Derya Tamer has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ayşe Nur Temtek
Department of Pathology, Ataturk University, Faculty of Medicine, Erzurum, Turkey
1 shared publication - Ayşe Nurseli Sulumer
Atatürk University
1 shared publication - Bahri Avcı
Atatürk University
1 shared publication - Esra Palabiyik
Department of Molecular Biology and Genetics, Ağrı İbrahim Çeçen University, Ağrı, Turkey
1 shared publication - Hakan Aşkın
Atatürk University
1 shared publication - Handan Uğuz
Atatürk University
1 shared publication
Latest Publications
- 30 September 2025
- Published by Journal of Anatolian Environmental and Animal Sciences in Journal of Anatolian Environmental and Animal Sciences
- Vol. 10 (5) , 693-702
Effectiveness of Cream Containing Medicinal Plants in the Treatment of Second Degree Burns: Biochemical and Histopathological Investigation
Burn injuries represent severe pathophysiological conditions characterized by increased oxidative stress and impaired tissue integrity, necessitating effective therapeutic interventions. This study evaluates the biochemical and histopathological effects of a novel cream formulation containing Juglans regia leaf extract, Argania spinosa kernel oil, Prunus dulcis oil, and Lavandula angustifolia oil on second-degree burn wounds. Using a Wistar-albino rat model, oxidative stress markers, including superoxide dismutase (SOD) and malondialdehyde (MDA), were analyzed alongside histopathological assessments to determine the formulation’s therapeutic potential. The results demonstrated a significant increase in SOD levels and a concurrent reduction in MDA levels in the treatment group, suggesting an enhanced antioxidant response and reduced lipid peroxidation. Histopathological evaluations revealed accelerated epithelialization, increased fibroblast activity, and improved keratinization compared to the burn control and silver sulfadiazine groups. These findings indicate that the tested formulation effectively mitigates oxidative damage while promoting tissue regeneration. As a potential alternative to conventional burn treatments, this plant-based formulation may offer an innovative and cost-effective therapeutic strategy for managing second-degree burns. However, further clinical studies are required to confirm its efficacy in human applications.
- 30 September 2025
- Published by Journal of Anatolian Environmental and Animal Sciences in Journal of Anatolian Environmental and Animal Sciences
- Vol. 10 (5) , 693-702
Effectiveness of Cream Containing Medicinal Plants in the Treatment of Second Degree Burns: Biochemical and Histopathological Investigation
Burn injuries represent severe pathophysiological conditions characterized by increased oxidative stress and impaired tissue integrity, necessitating effective therapeutic interventions. This study evaluates the biochemical and histopathological effects of a novel cream formulation containing Juglans regia leaf extract, Argania spinosa kernel oil, Prunus dulcis oil, and Lavandula angustifolia oil on second-degree burn wounds. Using a Wistar-albino rat model, oxidative stress markers, including superoxide dismutase (SOD) and malondialdehyde (MDA), were analyzed alongside histopathological assessments to determine the formulation’s therapeutic potential. The results demonstrated a significant increase in SOD levels and a concurrent reduction in MDA levels in the treatment group, suggesting an enhanced antioxidant response and reduced lipid peroxidation. Histopathological evaluations revealed accelerated epithelialization, increased fibroblast activity, and improved keratinization compared to the burn control and silver sulfadiazine groups. These findings indicate that the tested formulation effectively mitigates oxidative damage while promoting tissue regeneration. As a potential alternative to conventional burn treatments, this plant-based formulation may offer an innovative and cost-effective therapeutic strategy for managing second-degree burns. However, further clinical studies are required to confirm its efficacy in human applications.
- Open Access
- 3 January 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (1) , 149-153
Primary pulmonary Ewing sarcoma: a rare case report
Ewing sarcoma (ES) is a malignant soft tissue tumor that consists of undifferentiated neuroectodermal cells. The anatomical sites of ES are commonly the pelvis and long bones. Metastasis is the cause of the most prevalent pulmonary ES. The primary lung origin of ES is extremely uncommon. Here, we report a rare case of primary pulmonary ES diagnosed from cytology and biopsy material. A chest X-ray revealed a lesion with a 9 × 7.5 cm diameter in the pericardiac area of the right lung. Clinical and radiological examinations (computed tomography and positron emission tomography) demonstrated that the lesion was a primary lesion. No distant metastasis was detected. Bronchoscopy-guided fine-needle aspiration and cytological analysis of the lesion revealed uniformly shaped small round cell morphology. Immunohistochemistry performed on the cell block produced positive results for CD99 and FLI-1. These immunohistochemical findings support the ES diagnosis.
- 3 January 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (1) , 149-153
Open AccessPrimary pulmonary Ewing sarcoma: a rare case report
Ewing sarcoma (ES) is a malignant soft tissue tumor that consists of undifferentiated neuroectodermal cells. The anatomical sites of ES are commonly the pelvis and long bones. Metastasis is the cause of the most prevalent pulmonary ES. The primary lung origin of ES is extremely uncommon. Here, we report a rare case of primary pulmonary ES diagnosed from cytology and biopsy material. A chest X-ray revealed a lesion with a 9 × 7.5 cm diameter in the pericardiac area of the right lung. Clinical and radiological examinations (computed tomography and positron emission tomography) demonstrated that the lesion was a primary lesion. No distant metastasis was detected. Bronchoscopy-guided fine-needle aspiration and cytological analysis of the lesion revealed uniformly shaped small round cell morphology. Immunohistochemistry performed on the cell block produced positive results for CD99 and FLI-1. These immunohistochemical findings support the ES diagnosis.